{"id":17909,"date":"2022-03-02T14:47:47","date_gmt":"2022-03-02T20:47:47","guid":{"rendered":"https:\/\/wwwtest.cancer.wisc.edu\/research\/?post_type=tribe_events&#038;p=17909"},"modified":"2022-03-02T14:48:48","modified_gmt":"2022-03-02T20:48:48","slug":"spring-warf-therapeutics-program-proposal-deadline","status":"publish","type":"tribe_events","link":"https:\/\/wwwtest.cancer.wisc.edu\/research\/event\/spring-warf-therapeutics-program-proposal-deadline\/","title":{"rendered":"Spring WARF Therapeutics Program Proposal Deadline"},"content":{"rendered":"<p><a href=\"https:\/\/www.warf.org\/warf-therapeutics\/\" target=\"_blank\" rel=\"noopener\">WARF Therapeutics<\/a> collaborates with researchers to advance their work closer to clinical testing, a \u201cbench to bedside\u201d approach. The program invests in the development of drug-like molecules using industry-centric drug discovery resources and approaches led by a team of preclinical drug discovery experts.<\/p>\n<p>We encourage researchers to meet with <a href=\"jyoung@warf.org\">Jon Young<\/a> to discuss their program and learn more about WARF Therapeutics. Principal investigators are invited to submit stage 0 and stage 1 project proposals by April 15, 2022, which will be reviewed at our spring Scientific Advisory Board meeting on May 16. Please review our new <a href=\"https:\/\/www.warf.org\/warf-therapeutics\/funding-grant-mechanisms\/\" target=\"_blank\" rel=\"noopener\">funding mechanisms<\/a> that were recently initiated.<\/p>\n<p><strong>Eligibility<\/strong><\/p>\n<ul>\n<li>UW-Madison or Morgridge Institute for Research principal investigators<\/li>\n<li>Novel disease targets that require <a href=\"https:\/\/www.warf.org\/warf-therapeutics\/funding-grant-mechanisms\/\" target=\"_blank\" rel=\"noopener\">target validation<\/a><\/li>\n<li>Translational research with a validated target and therapeutic disease hypothesis<\/li>\n<li>Patent not required<\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.warf.org\/warf-therapeutics\/warf-therapeutics-process\/\" target=\"_blank\" rel=\"noopener\">Learn more and submit!<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>WARF Therapeutics collaborates with researchers to advance their work closer to clinical testing, a \u201cbench to bedside\u201d approach. The program invests in the development of drug-like molecules using industry-centric drug discovery resources and approaches led &hellip;<\/p>\n","protected":false},"author":43,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0},"tags":[],"tribe_events_cat":[],"acf":[],"_links":{"self":[{"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/tribe_events\/17909"}],"collection":[{"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/comments?post=17909"}],"version-history":[{"count":2,"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/tribe_events\/17909\/revisions"}],"predecessor-version":[{"id":17913,"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/tribe_events\/17909\/revisions\/17913"}],"wp:attachment":[{"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/media?parent=17909"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/tags?post=17909"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/wwwtest.cancer.wisc.edu\/research\/wp-json\/wp\/v2\/tribe_events_cat?post=17909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}